2m 2m 2m 2m 2m 2m 2m
Biogen (BIIB)
NASDAQ
$197.12-$2.94 (-1.47%)
Price as of Jun 15, 2026 7:20 PM EDT- $29.5BMarket Cap
- 53.12%1-Year Change
- Drug Manufacturers - GeneralIndustry
Biogen (BIIB)
$197.12-$2.94 (-1.47%)
BIIB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $200.05 | ||
Change | +$0.09 (+0.05%) | ||
Open | $200.57 | ||
High | $203.45 | ||
Low | $199.06 | ||
Previous Close | $199.96 | ||
Volume | 837,294 | ||
30-Day Average Volume | 1,108,137 | ||
1-Week Change | 2.41% | ||
1-Month Change | 0.35% | ||
1-Year Change | 53.12% | ||
3-Year Change | -36.17% | ||
5-Year Change | -49.56% | ||
Fundamentals | |||
Shares Outstanding | 147.6M | ||
Total Assets | $29.5B | ||
Market Cap | $29.5B | ||
Enterprise Value | $32.4B | ||
Period: QTR TTM FY | |||
Revenue | $1.8B | ||
Net Income | $319.5M | ||
Free Cash Flow | $594.3M | ||
EBIT | $445.3M | ||
EBITDA | $649.7M | ||
Net Working Capital | $6.2B | ||
EPS | $2.15 | ||
Enterprise Value/EBITDA | 50 | ||
Enterprise Value/Revenue | 19 | ||
P/B | 2 | ||
P/E | 93 | ||
PEG | 0 | ||
Price/Free Cash Flow | 50 | ||
Price/Operating Cash Flow | 46 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue